SR ONE CAPITAL MANAGEMENT, LP Q1 2022 Filing

Filed May 10, 2022

Portfolio Value

$195.3B

Holdings

3

Report Date

Q1 2022

Filing Type

13F-HR

All Holdings (3 positions)

#StockSharesValue% PortfolioType
1
DSGNDESIGN THERAPEUTICS INC
5,626,476$90.9B46.52%
2
ACLXARCELLX INC.
5,500,007$77.1B39.48%
3
EFTREFFECTOR THERAPEUTICS INC
6,822,114$27.4B14.01%